Ultragenyx Pharmaceutical reported $-72816000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Epizyme EPZM:US $ -65.83M 1.47M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Insmed INSM:US $ -115292000 1.41M
IONIS PHARMACEUT IONS:US $ -84M 3M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Kyowa Hakko Kirin 4151:JP Y 10788M 4154M
Macrogenics MGNX:US $ -52.89M 12.95M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Moderna Inc MRNA:US 3.55B 489M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Puma Biotechnology PBYI:US $ -20.14M 15.04M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
Vital Therapies VTL:US $ -19.29M 1.36M
Xoma XOMA:US $ -4.44M 2.2M